406 related articles for article (PubMed ID: 12438528)
1. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress.
Esposito P; Chandler N; Kandere K; Basu S; Jacobson S; Connolly R; Tutor D; Theoharides TC
J Pharmacol Exp Ther; 2002 Dec; 303(3):1061-6. PubMed ID: 12438528
[TBL] [Abstract][Full Text] [Related]
2. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
[TBL] [Abstract][Full Text] [Related]
3. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Esposito P; Gheorghe D; Kandere K; Pang X; Connolly R; Jacobson S; Theoharides TC
Brain Res; 2001 Jan; 888(1):117-127. PubMed ID: 11146058
[TBL] [Abstract][Full Text] [Related]
4. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.
Cao J; Boucher W; Kempuraj D; Donelan JM; Theoharides TC
J Urol; 2006 Sep; 176(3):1208-13. PubMed ID: 16890727
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.
Keita AV; Söderholm JD; Ericson AC
Neurogastroenterol Motil; 2010 Jul; 22(7):770-8, e221-2. PubMed ID: 20149111
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
[TBL] [Abstract][Full Text] [Related]
7. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process.
Pang X; Alexacos N; Letourneau R; Seretakis D; Gao W; Boucher W; Cochrane DE; Theoharides TC
J Pharmacol Exp Ther; 1998 Oct; 287(1):307-14. PubMed ID: 9765351
[TBL] [Abstract][Full Text] [Related]
8. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
9. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
10. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
Singh LK; Pang X; Alexacos N; Letourneau R; Theoharides TC
Brain Behav Immun; 1999 Sep; 13(3):225-39. PubMed ID: 10469524
[TBL] [Abstract][Full Text] [Related]
11. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
Bale TL; Contarino A; Smith GW; Chan R; Gold LH; Sawchenko PE; Koob GF; Vale WW; Lee KF
Nat Genet; 2000 Apr; 24(4):410-4. PubMed ID: 10742108
[TBL] [Abstract][Full Text] [Related]
12. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
[TBL] [Abstract][Full Text] [Related]
13. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.
Wallon C; Yang PC; Keita AV; Ericson AC; McKay DM; Sherman PM; Perdue MH; Söderholm JD
Gut; 2008 Jan; 57(1):50-8. PubMed ID: 17525093
[TBL] [Abstract][Full Text] [Related]
15. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism.
Vanuytsel T; van Wanrooy S; Vanheel H; Vanormelingen C; Verschueren S; Houben E; Salim Rasoel S; Tόth J; Holvoet L; Farré R; Van Oudenhove L; Boeckxstaens G; Verbeke K; Tack J
Gut; 2014 Aug; 63(8):1293-9. PubMed ID: 24153250
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
17. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.
O'Kane M; Murphy EP; Kirby B
Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421
[TBL] [Abstract][Full Text] [Related]
18. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.
Kishimoto T; Radulovic J; Radulovic M; Lin CR; Schrick C; Hooshmand F; Hermanson O; Rosenfeld MG; Spiess J
Nat Genet; 2000 Apr; 24(4):415-9. PubMed ID: 10742109
[TBL] [Abstract][Full Text] [Related]
19. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice.
Huang M; Pang X; Karalis K; Theoharides TC
Cardiovasc Res; 2003 Jul; 59(1):241-9. PubMed ID: 12829195
[TBL] [Abstract][Full Text] [Related]
20. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
